Comparative assessment of LDL-C and VLDL-C estimation in familial combined hyperlipidemia using Sampson’s, Martin’s and Friedewald’s equations
نویسندگان
چکیده
Abstract Background Sampson et al. developed a novel method to estimate very low-density lipoprotein cholesterol (VLDL-C) and (LDL-C) in the setting of hypertriglyceridemia. Familial Combined Hyperlipidemia (FCHL) is common primary dyslipidemia which composition interferes with LDL-C estimation. This study aimed evaluate performance using this new (LDL-S) compared estimated by Friedewald’s Martin eq. (LDL-F, LDL-M) FCHL. Methods Data were collected from 340 subjects confirmed Concordance for VLDL-C measured ultracentrifugation these measures Sampson’s, Martin’s equations was performed correlation coefficients, root mean squared error (RMSE) bias. Also, concordance misclassified metrics according (< 70 < 100 mg/dL) Apo B 80 65 thresholds assessed. Results Sampson’s equation more accurate (RMSE 11.21 mg/dL; R 2 = 0.88) 13.15 0.875) 13.7 0.869). When assessing LDL-C, had highest lowest RMSE other 19.99 0.840). Comparing strength across triglyceride levels, showed consistently improved correlations formulas increasing triglycerides FCHL phenotype mixed dyslipidemia. also treatment goals. Conclusions In FCHL, estimation formula higher lipid targets assessed obtained equations. Implementation could improve monitoring
منابع مشابه
Plasma triglyceride and LDL heterogeneity in familial combined hyperlipidemia.
Familial combined hyperlipidemia (FCHL) is a genetic disorder characterized by increases in plasma cholesterol and/or triglyceride, elevated apolipoprotein B, and heterogeneous low density lipoprotein (LDL). To examine the relation between plasma triglyceride concentrations and LDL heterogeneity, 13 hypertriglyceridemic FCHL patients with a predominance of small LDL (LDL subclass phenotype B) w...
متن کاملApolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: effects on LDL-cholesterol and apolipoproteins B and C-III.
The underlying genetic abnormalities in familial combined hyperlipidemia (FCH) have not been elucidated, although previous association and linkage studies have implicated the apoA-I/C-III/A-IV gene cluster. We now report studies of this cluster in 18 probands, 390 family members (hyperlipidemic relatives, n = 179; normolipidemic relatives, n = 211), and 177 spouses. Three restriction enzyme pol...
متن کاملpatterns and variations in native and non-native interlanguage pragmatic rating: effects of rater training, intercultural proficiency, and self-assessment
although there are studies on pragmatic assessment, to date, literature has been almost silent about native and non-native english raters’ criteria for the assessment of efl learners’ pragmatic performance. focusing on this topic, this study pursued four purposes. the first one was to find criteria for rating the speech acts of apology and refusal in l2 by native and non-native english teachers...
15 صفحه اولassessment of deep word knowledge in elementary and advanced iranian efl learners: a comparison of selective and productive wat tasks
testing plays a vital role in any language teaching program. it allows teachers and stakeholders, including program administrators, parents, admissions officers and prospective employers to be assured that the learners are progressing according to an accepted standard (douglas, 2010). the problems currently facing language testers have both practical and theoretical implications but the first i...
Pravastatin effectively lowers LDL cholesterol in familial combined hyperlipidemia without changing LDL subclass pattern.
Familial combined hyperlipidemia (FCHL) is the most common genetic lipid disorder among young survivors of myocardial infarction. Elevations of plasma total and low-density lipoprotein (LDL) cholesterol and the prevalence of small, dense LDL particles are both involved in the high coronary risk of FCHL patients. We investigated the ability of pravastatin to favorably correct plasma lipid and li...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Lipids in Health and Disease
سال: 2021
ISSN: ['1476-511X']
DOI: https://doi.org/10.1186/s12944-021-01471-3